This is an auto-generated stub page built from atlas entry frontmatter. A richer
hand-crafted page is planned. See the
atlas source
for the full entry including detailed body sections.
hepatitis-c
Hepatitis C
HCV (Hepacivirus; positive-sense ssRNA; genotypes 1-6) infects 58M people globally; NS3/4A cleaves MAVS → IRF3 not activated → chronicity in 80%; direct-acting antivirals (SOF/VEL, GLE/PIB) achieve >95% cure; cirrhosis → HCC risk 1-5%/year; no vaccine exists.
Entry Metadata
| Field | Value |
|---|---|
| ID | hepatitis-c |
| Name | Hepatitis C |
| Status | draft |
| Last reviewed | 2026-06-08 |
| Atlas | 01-human |
| Scale | 07-system |
Cross-Atlas Connections
Sources
- Li XD, Sun L, Seth RB, Pineda G, Chen ZJ. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci USA. 2005;102(49):17717-17722. · PubMed 16301520
- Ghany MG, Morgan TR; AASLD-IDSA HCV Guidance Panel. Hepatitis C Guidance 2019 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Hepatology. 2020;71(2):686-721. · PubMed 31816268